Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. MERIMSKY O; HAREUVENI M; BARAK V; SPERBER F; ESHKOL Z; CHAITCHIK S
   ELEVATED BREAST-CANCER SERUM MARKERS IN OTHERWISE HEALTHY WOMEN
   Oncology Reports
   
   O. Merimsky et al., "ELEVATED BREAST-CANCER SERUM MARKERS IN OTHERWISE HEALTHY WOMEN", Oncology Reports, 4(4), 1997, pp. 829-832
2. MERIMSKY O; KOVNER F; INBAR M; HAREUVENI M; ROSENBOIM Y; CHAITCHIK S
   TAMOXIFEN FOR DISEASE-NEGATIVE BUT MCA-POSITIVE BREAST-CANCER PATIENTS
   Oncology Reports
   
   O. Merimsky et al., "TAMOXIFEN FOR DISEASE-NEGATIVE BUT MCA-POSITIVE BREAST-CANCER PATIENTS", Oncology Reports, 4(4), 1997, pp. 843-847
3. GEVA E; ARAVA J; LERNERGEVA L; HAREUVENI M; LESSING JB; BALLAS S; AMIT A
   THE RATION BETWEEN CARCINOMA ANTIGEN-125 LEVELS IN THE SEMINAL PLASMAAND SERUM MAY BE A MARKER FOR FERTILIZATION IN INTRACYTOPLASMIC SPERMINJECTION
   Fertility and sterility
   
   E. Geva et al., "THE RATION BETWEEN CARCINOMA ANTIGEN-125 LEVELS IN THE SEMINAL PLASMAAND SERUM MAY BE A MARKER FOR FERTILIZATION IN INTRACYTOPLASMIC SPERMINJECTION", Fertility and sterility, 68(6), 1997, pp. 1120-1124
4. MATZKIN H; LAUFER M; CHEN JZ; HAREUVENI M; BRAF Z
   EFFECT OF ELECTIVE PROLONGED URETHRAL CATHETERIZATION ON SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATION
   Urology
   
   H. Matzkin et al., "EFFECT OF ELECTIVE PROLONGED URETHRAL CATHETERIZATION ON SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATION", Urology, 48(1), 1996, pp. 63-66
5. KOVNER F; MERIMSKY O; HAREUVENI M; WIGLER N; CHAITCHIK S
   TREATMENT OF DISEASE-NEGATIVE BUT MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN-POSITIVE BREAST-CANCER PATIENTS WITH TAMOXIFEN - PRELIMINARY-RESULTS OF A PROSPECTIVE CONTROLLED RANDOMIZED TRIAL
   Cancer chemotherapy and pharmacology
   
   F. Kovner et al., "TREATMENT OF DISEASE-NEGATIVE BUT MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN-POSITIVE BREAST-CANCER PATIENTS WITH TAMOXIFEN - PRELIMINARY-RESULTS OF A PROSPECTIVE CONTROLLED RANDOMIZED TRIAL", Cancer chemotherapy and pharmacology, 35(1), 1994, pp. 80-83
6. ACRES RB; HAREUVENI M; BALLOUL JM; KIENY MP
   VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN
   Journal of immunotherapy with emphasis on tumor immunology
   
   R.B. Acres et al., "VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN", Journal of immunotherapy with emphasis on tumor immunology, 14(2), 1993, pp. 136-143
7. MERIMSKY O; HAREUVENI M; INBAR M; LIMOR R; WITENBERG B; CHAITCHIK S
   MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND CA-125 IN EVALUATION OF CHEMOTHERAPY RESULTS IN OVARIAN-CANCER PATIENTS
   Diagnostic oncology
   
   O. Merimsky et al., "MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND CA-125 IN EVALUATION OF CHEMOTHERAPY RESULTS IN OVARIAN-CANCER PATIENTS", Diagnostic oncology, 3(3), 1993, pp. 117-120
8. MERIMSKY O; HAREUVENI M; INBAR M; HOREV J; KEYDAR I; KOVNER F; CHAITCHIK S
   INCREASING SERUM LEVELS OF MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND MUCINOUS ANTIGEN-H23 IN CLINICALLY DISEASE-FREE BREAST-CANCER PATIENTS
   Diagnostic oncology
   
   O. Merimsky et al., "INCREASING SERUM LEVELS OF MUCIN-LIKE CARCINOMA-ASSOCIATED ANTIGEN AND MUCINOUS ANTIGEN-H23 IN CLINICALLY DISEASE-FREE BREAST-CANCER PATIENTS", Diagnostic oncology, 3(2), 1993, pp. 61-66